2016 American Transplant Congress
Kidney Transplants from Anuric Deceased Donors on Renal Replacement Therapy.
Transplantation, California Pacific Medical Center, San Francisco, CA.
Transplantation of deceased donor kidneys with Acute Kidney Injury (AKI) has become a generally well accepted practice with excellent results documented in the literature. The…2016 American Transplant Congress
SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes.
A lot of efforts have been done to identify the risk factors that tend to diminish the incidence of delayed graft function (DGF). Recently, the…2016 American Transplant Congress
Superior Waitlist and Equivalent Transplant Outcomes Among Hepatitis C RNA-Positive Patients Who Are Willing to Accept Hepatitis C Seropositive Kidneys.
Background: kidney transplantation from hepatitis C seropositive (HCV+) donors may benefit hepatitis C RNA-positive (RNA+) candidates, but it is not clear how the acceptance/listing status…2016 American Transplant Congress
The Prevailing Preference for Left Nephrectomy in Living Donor Transplantation Does Not Adversely Affect Long Term Donor Outcome.
Background: There is a world-wide prevailing clinical bias for removing the left kidney for living donor renal transplant. Both the retrieval and implantation of the…2016 American Transplant Congress
Validation of the Newly Developed North America Islet Donor Scoring System in the Medium Volume Islet Transplant Center.
Background.North America Islet Donor Scoring (NAIDS) system has been recently developed for selection of the optimal pancreas donor based on analysis of the results from…2016 American Transplant Congress
Pediatric En Bloc Kidney Transplants Reduce DGF and Are Misrepresented by the KDPI.
Controversy exists regarding optimal use of kidneys from small pediatric donors (SPDs). The study purpose was to compare outcomes between single and dual en bloc…2016 American Transplant Congress
Increased Utilization of High Risk Deceased Donors with Share 35 Does Not Affect Outcomes in Liver Transplantation.
Background: Demand for livers from deceased donors exceeds supply after Share 35 in June 2013. This leads liver transplant centers to consider high risk deceased…2016 American Transplant Congress
The Impact of Total Ischaemic Time, Donor Age and the Pathway of Donor Death on Graft Outcomes After Deceased Donor Kidney Transplantation.
Prolonged ischaemia is a known risk factor for delayed graft function and its interaction with donor characteristics, the pathways of donor death and graft outcomes…2016 American Transplant Congress
What Living Organ Donors See as Their Unmet Needs in the United States.
Study PurposeTo collect data on what living organ donors themselves say they want and need to make living organ donation safer and easier.MethodFor 12 months,…2016 American Transplant Congress
Everolimus (EVR) versus Mycophenolate Sodium (MPS) for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin (r-ATG) and Tacrolimus (TAC).
Introduction: There is no standard of care immunosuppressive regimen for recipients of kidneys recovered from expanded criteria donors. Several centers use r-ATG induction due to…
- « Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 46
- Next Page »